MARKET

MDWD

MDWD

Mediwound
NASDAQ
18.46
+0.20
+1.10%
After Hours: 18.16 -0.3 -1.63% 17:43 12/31 EST
OPEN
18.73
PREV CLOSE
18.26
HIGH
18.77
LOW
18.21
VOLUME
72.03K
TURNOVER
--
52 WEEK HIGH
22.51
52 WEEK LOW
14.14
MARKET CAP
236.68M
P/E (TTM)
-9.7224
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MDWD last week (1222-1226)?
Weekly Report · 12/29/2025 09:53
Weekly Report: what happened at MDWD last week (1215-1219)?
Weekly Report · 12/22/2025 09:53
Weekly Report: what happened at MDWD last week (1208-1212)?
Weekly Report · 12/15/2025 09:58
Analysts’ Top Healthcare Picks: Elanco Animal Health (ELAN), Mediwound (MDWD)
TipRanks · 12/10/2025 18:30
MediWound Announces Peer-Reviewed Publication Of New Prospective Clinical Data Showing NexoBrid Substantially Reduces Embedded Particles Associated With Traumatic Tattoos Following Abrasion And Blast Injuries
Benzinga · 12/10/2025 12:13
MediWound reports clinical data on NexoBrid’s effectiveness
TipRanks · 12/10/2025 12:10
MediWound Study Finds NexoBrid Removes Over 90% of Traumatic Tattoo Pigments After Injuries
Reuters · 12/10/2025 12:00
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries
Barchart · 12/10/2025 06:00
More
About MDWD
Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues.; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.

Webull offers Mediwound Ltd stock information, including NASDAQ: MDWD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MDWD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MDWD stock methods without spending real money on the virtual paper trading platform.